HSA — authorised 28 September 2000
- Marketing authorisation holder: DANCO LABS LLC
- Status: likely_approved
HSA authorised Mifeprex on 28 September 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 28 September 2000.
DANCO LABS LLC holds the Singaporean marketing authorisation.